儿童闭塞性细支气管炎研究进展

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1210 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要儿童闭塞性细支气管炎（BO）是一种儿童中极其少见的慢性阻塞性肺疾病，其发展的最终结果是气道管腔的完全狭窄或闭塞。目前认为其发病机制主要是各种炎症和免疫反应的相互作用使得肺组织纤维增生。临床表现各不相同，大多表现为咳嗽、喘鸣、呼吸急促等，需结合临床表现、高分辨CT、肺功能等检查进行综合诊断。治疗上目前对儿童BO尚无特异性方法和统一的标准，临床上常常需要儿科医师进行全面的评估、监测并及时调整治疗方案。大多数患儿预后不良，少部分患儿可通过早期诊断及干预取得较好的疗效。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张詹明
	李昌崇

关键词 ：儿童, 细支气管炎, 闭塞性, 发病机制, 预后

通讯作者: 李昌崇，主任医师，博士生导师，Email：wzlichch@ 21cn.com。

作者简介: 张詹明（1990-），女，浙江温州人，硕士生。

链接本文:

https://xb.wmu.edu.cn/CN/ 或 https://xb.wmu.edu.cn/CN/Y2018/V48/I8/618

[1] LINO C A, BATISTA A K, SOARES M A, et al. Bronchiolitis obliterans: clinical and radiological profile of children followed-up in a reference outpatient clinic[J]. Rev Paul Pediatr, 2013, 31(1): 10-16.
[2] LION T. Adenovirus infections in immunocompetent and immunocompromised patients[J]. Clin Microbiol Rev, 2014, 27(3): 441-462.
[3] DE BEATS F. Bronchiolitis obliterans in children: a ghostly journey to the origin[J]. Allergol Immunopathol (Madr), 2011, 39 (5): 251-252.
[4] MADILL J, AGHDASSI E, ARENDT B M, et al. Oxidative stress and nutritional intakes in lung patients with bronchiolitis obliterans syndrome[J]. Transplant Proc, 2009, 41(9): 3838-3844.
[5] REGAMEY N, JEFFERY P K, ALTON E W, et al. Airway remodelling and its relationship to inflammation in cystic fibrosis[J]. Thorax, 2011, 66(7): 624-629.
[6] TRISCHLER J, MULLER C M, KONITZER S, et al. Elevated exhaled leukotriene B4 in the small airway compartment in children with asthma[J]. Ann Allergy Asthma Immunol, 2015, 114(2): 111-116.
[7] MALLOL J, AGUIRRE V, ESPINOSA V. Increased oxidative stress in children with post infectious bronchiolitis obliterans[J]. Allergol Immunopathol (Madr), 2011, 39(5): 253-258.
[8] KREBS R, TIKKANEN J M, ROPPONEN J O, et al. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchi-olitis[J]. Am J Pathol, 2012, 181(5): 1607-1620.
[9] BORTHWICK L A, SUNNY S S, OLIPHANT V, et al. Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway[J]. Eur Respir J, 2011, 37(5): 1237-1247.
[10] NEUJAHR D C, LARSEN C P. Regulatory T cells in lung transplantation-an emerging concept[J]. Semin Immunopathol, 2011, 33(2): 117-127.
[11] HACHEM R R, YUSEN R D, MEYERS B F, et al. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation[J]. J Heart Lung Transplant, 2010, 29(9): 973-980.
[12] ZHANG L, SILVA F A. Bronchiolitis obliterans in children [J]. J Pediatr (Rio J), 2000, 76(3): 185-192.
[13] TOMIKAWA S O, RODRIGUES J C. Current research on pediatric patients with bronchiolitis obliterans in Brazil[J]. Intractable Rare Dis Res, 2015, 4(1): 7-11.
[14] COLOM A J, MAFFEY A, BOURNISSEN F G, et al. Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up[J]. Thorax, 2015, 70(2): 169-174.
[15] 王维, 申昆玲, 曾津津. 儿童闭塞性细支气管炎42例临床分析[J]. 中华儿科杂志, 2008, 46(10): 732-738.
[16] KOH Y Y, JUNG D E, KOH J Y, et al. Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis ob-literans[J]. Chest, 2007, 131(5): 1454-1460.
[17] ECKRICH J, HERRMANN E, VOSS S, et al. Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans[J]. Lung, 2016, 194(4): 571-579.
[18] FISCHER G B, SARRIA E E, MATTIELLO R, et al. Post infectious bronchiolitis obliterans in children[J]. Paediatr Respir Rev, 2010, 11(4): 233-239.
[19] CHAMPS N S, LASMAR L M, CAMARGOS P A, et al. Post-infectious bronchiolitis obliterans in children[J]. J Pediatr (Rio J), 2011, 87(3): 187-198.
[20] COLOM A J, TEPER A M. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children[J]. Pediatr Pulmonol, 2009, 44(11): 1065-1069.
[21] YOON H M, LEE J S, HWANG J Y, et al. Postinfectious bronchiolitis obliterans in children: ct features that predict responsiveness to pulse methylprednis-olone[J]. Brit J Radiol, 2015, 88(1049): 20140478.
[22] TANOU K, XAIDARA A, KADITIS A G. Efficacy of pulse methylprednisolone in a pediatric case of postinfectious bronchiolitis obliterans[J]. Pediatr Pulmonol, 2015, 50(5): E13-E16.
[23] 赵顺英. 闭塞性细支气管炎的诊治[J]. 中国实用儿科杂志, 2006, 21(4): 241-243
[24] ROSEWICH M, ZISSLER U M, KHEIRI T, et al. Airway inflammation in children and adolescents with bronchiolitis obliterans[J]. Cytokine, 2015, 73(1): 156-162.
[25] LEE S J, WOLFF D, KITKO C, et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report[J]. Biol Blood Marrow Transplant, 2015, 21(6): 984-999.
[26] TU Z L, ZHOU Z Y, XU H C, et al. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats[J]. J Cardiothorac Surg, 2017, 12(1): 43-48.
[27] KIM S W, RHEE C K, KIM Y J, et al. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation[J]. Respir Res, 2016, 17(1): 63-71.
[28] FAHRNI J A, BERRY G J, MORRIS R E, et al. Rapamycin inhibits development of obliterative airway disease in a murine heterotopic airway transplant model[J]. Transplantation, 1997, 63(4): 533-537.
[29] PELAIA G, VATRELLA A, BUSCETI M T, et al. Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD[J]. Ther Clin Risk Manag, 2015, 11: 1563-1572.
[30] KIM C K, KIM S W, KIM J S, et al. Bronchiolitis obliterans in the 1990s in Korea and the United States[J]. Chest, 2001, 120(4): 1101-1106.
[31] ZHAO C, LIU J, YANG H, et al. Mycoplasma pneumoniae-associated bronchiolitis obliterans following acute bronchiolitis [J]. Sci Rep, 2017, 7(1): 8478.
[32] 李思洁. 儿童闭塞性细支气管炎72例临床分析[D]. 重庆: 重庆医科大学, 2017.